OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026 BELLEVUE, WA / ACCESS Newswire / April 30, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare ...

MESA, AZ / ACCESS Newswire / April 30, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) ("the Company") today announced the ...

Insights From 100,000+ Employees Nationwide Reveal Where Benefits Consultants and Employers Can Focus Interventions to Stem ...

New research links serotonin to tinnitus severity, showing how antidepressant pathways may amplify symptoms. The findings ...

Acquisition adds high-payload herpes simplex virus (HSV) gene therapy targeting genetic skin dis-eases to LEO Pharma’s pipeline and further expands the company’s presence in rare dermatology• Combines ...

The company was recognized as a Leader in the Everest Group Revenue Cycle Management (RCM) Intelligent Operations PEAK Matrix® Assessment for its market impact, vision, and strategy in the healthcare ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Learnings from US study highlight urgent need for governance to ensure responsible AI use in the NHSA survey from Wolters Kluwer Health has highlighted the threat of shadow AI in healthcare and ...

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...

Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical Center. MIAMI, FL / ACCESS Newswire / April 30, 2026 / Telomir Pharmaceuticals, Inc.

The company is building the clinical intelligence and intervention layer to deliver whole-person cancer care at scale. NEW YORK CITY, NY / ACCESS Newswire / April 30, 2026 / Greatly Health, a ...

STOCKHOLM, SE / ACCESS Newswire / April 30, 2026 / Egetis Therapeutics (STO:EGTX) - Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (NASDAQ Stockholm:EGTX), today announced its participation ...